These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27000513)

  • 1. Small Bowel Dose Tolerance for Stereotactic Body Radiation Therapy.
    LaCouture TA; Xue J; Subedi G; Xu Q; Lee JT; Kubicek G; Asbell SO
    Semin Radiat Oncol; 2016 Apr; 26(2):157-64. PubMed ID: 27000513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimated Risk Level of Unified Stereotactic Body Radiation Therapy Dose Tolerance Limits for Spinal Cord.
    Grimm J; Sahgal A; Soltys SG; Luxton G; Patel A; Herbert S; Xue J; Ma L; Yorke E; Adler JR; Gibbs IC
    Semin Radiat Oncol; 2016 Apr; 26(2):165-71. PubMed ID: 27000514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery.
    Hiniker SM; Modlin LA; Choi CY; Atalar B; Seiger K; Binkley MS; Harris JP; Liao YJ; Fischbein N; Wang L; Ho A; Lo A; Chang SD; Harsh GR; Gibbs IC; Hancock SL; Li G; Adler JR; Soltys SG
    Semin Radiat Oncol; 2016 Apr; 26(2):97-104. PubMed ID: 27000505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction and Clinical Overview of the DVH Risk Map.
    Asbell SO; Grimm J; Xue J; Chew MS; LaCouture TA
    Semin Radiat Oncol; 2016 Apr; 26(2):89-96. PubMed ID: 27000504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity of Current Stereotactic Body Radiation Therapy Dose Constraints for Aorta and Major Vessels.
    Xue J; Kubicek G; Patel A; Goldsmith B; Asbell SO; LaCouture TA
    Semin Radiat Oncol; 2016 Apr; 26(2):135-9. PubMed ID: 27000510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-Volume Histogram Analysis of Stereotactic Body Radiotherapy Treatment of Pancreatic Cancer: A Focus on Duodenal Dose Constraints.
    Goldsmith C; Price P; Cross T; Loughlin S; Cowley I; Plowman N
    Semin Radiat Oncol; 2016 Apr; 26(2):149-56. PubMed ID: 27000512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-Response Model for Chest Wall Tolerance of Stereotactic Body Radiation Therapy.
    Kimsey F; McKay J; Gefter J; Milano MT; Moiseenko V; Grimm J; Berg R
    Semin Radiat Oncol; 2016 Apr; 26(2):129-34. PubMed ID: 27000509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT).
    Barney BM; Markovic SN; Laack NN; Miller RC; Sarkaria JN; Macdonald OK; Bauer HJ; Olivier KR
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):73-80. PubMed ID: 23920388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
    Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal Dose Tolerance in Patients Treated With Stereotactic Body Radiation Therapy.
    Nuyttens JJ; Moiseenko V; McLaughlin M; Jain S; Herbert S; Grimm J
    Semin Radiat Oncol; 2016 Apr; 26(2):120-8. PubMed ID: 27000508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low toxicity for lung tumors near the mediastinum treated with stereotactic body radiation therapy.
    Srivastava R; Asbell SO; Lacouture T; Kramer N; Pahlajani N; Xue J; Ahmad N; Chen Y; Croce R; Grimm J
    Pract Radiat Oncol; 2013; 3(2):130-7. PubMed ID: 24674316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract.
    Osmundson EC; Wu Y; Luxton G; Bazan JG; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):986-94. PubMed ID: 25659885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer.
    Kim DW; Cho LC; Straka C; Christie A; Lotan Y; Pistenmaa D; Kavanagh BD; Nanda A; Kueplian P; Brindle J; Cooley S; Perkins A; Raben D; Xie XJ; Timmerman RD
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):509-17. PubMed ID: 24929162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical appraisal of volumetric modulated arc therapy in stereotactic body radiation therapy for metastases to abdominal lymph nodes.
    Bignardi M; Cozzi L; Fogliata A; Lattuada P; Mancosu P; Navarria P; Urso G; Vigorito S; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1570-7. PubMed ID: 19880261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.
    Pettersson N; Nyman J; Johansson KA
    Radiother Oncol; 2009 Jun; 91(3):360-8. PubMed ID: 19410314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity after central versus peripheral lung stereotactic body radiation therapy: a propensity score matched-pair analysis.
    Mangona VS; Aneese AM; Marina O; Hymas RV; Ionascu D; Robertson JM; Gallardo LJ; Grills IS
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):124-32. PubMed ID: 25442337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
    Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
    Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multisession Radiosurgery for Hearing Preservation.
    Rashid A; Karam SD; Rashid B; Kim JH; Pang D; Jean W; Grimm J; Collins SP
    Semin Radiat Oncol; 2016 Apr; 26(2):105-11. PubMed ID: 27000506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice.
    Sahgal A; Weinberg V; Ma L; Chang E; Chao S; Muacevic A; Gorgulho A; Soltys S; Gerszten PC; Ryu S; Angelov L; Gibbs I; Wong CS; Larson DA
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):341-7. PubMed ID: 22713832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.